학술논문
Corrigendum: PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease(Front. Immunol., (2024), 14, (1326078), 10.3389/fimmu.2023.1326078)
Document Type
Erratum
Author
Kocheise, L.; Buescher, G.; Joerg, V.; Schmidt, C.; Glaser, F.; Sutter, J.P.; Fründt, T.W.; Lohse, A.W.; Huber, S.; von Felden, J.; Sebode, M.; Schulze, K.; Piseddu, I.; Vonderlin, J.; Tjwa, E.T.; Meunier, L.; Fianchi, F.; Dumortier, J.; Barciela, M.R.; Gevers, T.J.G.; Beretta-Piccoli, B.T.; Londoño, M.-C.; Frankova, S.; Goeggelmann, P.; Roesner, T.
Source
In: Frontiers in Immunology . (Frontiers in Immunology, 2024, 15)
Subject
Language
English
ISSN
16643224